3VE-10865-68980
4 vaccinations
1 coded response
55 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-15
- 2021-04-17
-
2021-04-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-07-12
- 2021-10-11
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-25
-
2022-01-01
Survey response — day 28, dose 2MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Nausea due to pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
- 2022-01-15
- 2022-03-05
-
2022-05-21
Dose 3 — Pfizer-BioNTech
- 2022-05-21
-
2022-05-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-23
- 2022-05-24
- 2022-05-25
- 2022-05-26
- 2022-05-27
- 2022-05-28
- 2022-06-04
- 2022-06-11
- 2022-06-18
- 2022-06-25
- 2022-07-02
- 2022-08-20
-
2022-10-16
Dose 4 — Pfizer-BioNTech
- 2022-10-16
-
2022-10-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-23
- 2022-10-30
- 2022-11-06
- 2022-11-14
- 2022-11-20
- 2022-11-28
- 2023-01-15
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-05-21 | Pfizer-BioNTech | No |
| 4 | 2022-10-16 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2
Symptoms: Nausea due to pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release